WO2008104573A2 - Hydrophilic coating - Google Patents
Hydrophilic coating Download PDFInfo
- Publication number
- WO2008104573A2 WO2008104573A2 PCT/EP2008/052397 EP2008052397W WO2008104573A2 WO 2008104573 A2 WO2008104573 A2 WO 2008104573A2 EP 2008052397 W EP2008052397 W EP 2008052397W WO 2008104573 A2 WO2008104573 A2 WO 2008104573A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coating
- coating formulation
- hydrophilic
- hydrophilic coating
- poly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D4/00—Coating compositions, e.g. paints, varnishes or lacquers, based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; Coating compositions, based on monomers of macromolecular compounds of groups C09D183/00 - C09D183/16
- C09D4/06—Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups C09D159/00 - C09D187/00
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/038—Macromolecular compounds which are rendered insoluble or differentially wettable
- G03F7/0388—Macromolecular compounds which are rendered insoluble or differentially wettable with ethylenic or acetylenic bands in the side chains of the photopolymer
Definitions
- This invention relates to a hydrophilic coating formulation for preparing a hydrophilic coating.
- the invention further relates to a coating system, a hydrophilic coating, a lubricious coating, use of a Norrish Type I and a Norrish Type Il photoinitiator in a lubricious coating, an article, a medical device or component and a method of forming a hydrophilic coating on a substrate.
- a lubricant applied to the outer and/or inner surface to facilitate insertion into and removal from the body and/or to facilitate drainage of fluids from the body.
- Lubricious properties are also required so as to minimize soft tissue damage upon insertion or removal.
- such medical devices may have a hydrophilic surface coating or layer which becomes lubricious and attains low-friction properties upon wetting, i.e. applying a wetting fluid for a certain time period prior to insertion of the device into the body of a patient.
- a coating or layer which becomes lubricious after wetting is hereinafter referred to as a hydrophilic coating.
- a coating obtained after wetting is hereinafter referred to as a lubricious coating.
- a lubricious coating that exhibits an improved wear resistance in addition to a high lubricity.
- hydrophilic coatings obtainable by curing the hydrophilic coating formulation according to the invention are extremely wear resistant in tortuous tests compared to similar coatings known in the art.
- subjecting the coatings according to the invention to a particulates release test, as described in the examples results in a surprisingly low number of particles released from the coating. This is particularly advantageous for cardiovascular applications such as guide wires and catheters, in which the hydrophilic coating experiences serious torture and no particle release is tolerated.
- lubricious is defined as having a slippery surface.
- a coating on the outer or inner surface of a medical device, such as a catheter, is considered lubricious if (when wetted) it can be inserted into the intended body part without leading to injuries and/or causing unacceptable levels of discomfort to the subject.
- a coating is considered lubricious if it has a friction as measured on a Harland FTS5000 Friction Tester (HFT) of 20 g or less, preferably of 15 g or less, at a clamp-force of 300 g, a pull speed of 1 cm/s, and a temperature of 22°C.
- HFT Harland FTS5000 Friction Tester
- the term “wetted” is generally known in the art and - in a broad sense - means "containing water”.
- a wetted coating contains at least 10 wt% of water, based on the dry weight of the coating, preferably at least 50 wt%, based on the dry weight of the coating, more preferably at least 100 wt% based on the dry weight of the coating.
- a water uptake of about 300-500 wt% water is feasible.
- wetting fluids are treated or untreated water, water-containing mixtures with for example organic solvents or aqueous solutions comprising for example salts, proteins or polysaccharides.
- a wetting fluid can be a body fluid.
- the Norrish Type I and Norrish Type Il photoinitiators are used to cure the hydrophilic coating formulation according to the invention, for example using visible light or UV, electro-beam, or gamma radiation to form the hydrophilic coating.
- both Norrish Type I and Norrish Type Il photoinitiators are free-radical photoinitiators, but are distinguished by the process by which the initiating radicals are formed.
- Compounds that undergo unimolecular bond cleavage of the chromophore upon irradiation to generate radicals that initiate polymerization are termed Norrish Type I or homolytic photoinitiators.
- a Norrish Type Il photoinitiator generates radicals indirectly by hydrogen abstraction from a suitable synergist, which may be a low molecular weight compound or a polymer.
- the fragmentation can take place at a bond adjacent to the carbonyl group ( ⁇ -cleavage), at a bond in the ⁇ -position ( ⁇ -cleavage) or, in the case of particularly weak bonds (like C-S bonds or 0-0 bonds), elsewhere at a remote position.
- the most important fragmentation in photoinitiator molecules is the ⁇ -cleavage of the carbon-carbon bond between the carbonyl group and the alkyl residue in alkyl aryl ketones, which is known as the Norrish Type I reaction.
- the photoinitiator while being in the excited state, interacts with a second molecule (a coinitiator COI) to generate radicals in a bimolecular reaction as shown by formula (2), the photoinitiator is termed a NorrishType Il photoinitiator.
- the two main reaction pathways for Norrish Type Il photoinitiators are hydrogen abstraction by the excited initiator or photoinduced electron transfer, followed by fragmentation.
- Bimolecular hydrogen abstraction is a typical reaction of excited diaryl ketones.
- Photoinduced electron transfer is a more general process, which is not limited to a certain class of compounds.
- Norrish Type I or free-radical photoinitiators are benzoin derivatives, methylolbenzoin and 4-benzoyl-1 ,3-dioxolane derivatives, benzilketals, ⁇ , ⁇ -dialkoxyacetophenones, ⁇ -hydroxy alkylphenones, ⁇ - aminoalkylphenones, acylphosphine oxides, bisacylphosphine oxides, acylphosphine sulphides, halogenated acetophenone derivatives, and the like.
- Type I photoinitiators are lrgacure 2959 (2-hydroxy-4'-(2-hydroxyethoxy)-2- methyl propiophenone), lrgacure 651 (benzildimethyl ketal or 2,2-dimethoxy-1 ,2- diphenylethanone, Ciba-Geigy), lrgacure 184 (1-hydroxy-cyclohexyl-phenyl ketone as - A -
- Ciba-Geigy the active component
- Darocur 1 173 (2-hydroxy-2-methyl-1- phenylpropan-1-one as the active component
- Ciba-Geigy the active component
- lrgacure 907 (2-methyl-1- [4-(methylthio)phenyl]-2-morpholino propan-1-one
- Ciba-Geigy lrgacure 369
- Esacure KIP 150 poly ⁇ 2-hydroxy-2-methyl-1-[4-(1- methylvinyl)phenyl]propan-1-one ⁇
- Fratelli Lamberti Esacure KIP 100 F (blend of poly ⁇ 2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]propan-1-one ⁇ and 2-hydroxy-2-methyl- 1-phen
- Norrish Type Il photoinitiators that can be used in the hydrophilic coating formulation according to the invention include aromatic ketones such as benzophenone, xanthone, derivatives of benzophenone (e.g. chlorobenzophenone), blends of benzophenone and benzophenone derivatives (e.g. Photocure 81 , a 50/50 blend of 4-methyl-benzophenone and benzophenone), Michler's Ketone, Ethyl Michler's Ketone, thioxanthone and other xanthone derivatives like Quantacure ITX (isopropyl thioxanthone), benzil, anthraquinones (e.g.
- photoinitiators 2-ethyl anthraquinone), coumarin, or chemical derivatives or combinations of these photoinitiators.
- Preferred are Norrish Type I and Norrish Type Il photoinitiators which are water-soluble or can be adjusted to become water-soluble, also preferred photoinitiators are polymeric or polymerisable photoinitiators.
- the total amount of photoinitiator in the hydrophilic coating formulation is between 0.2 and 10 wt%, preferably between 0.8 and 8 wt%, based on the total weight of dry the coating.
- the hydrophilic coating formulation also comprises a supporting polymer comprising a backbone and at least 2 reactive moieties capable of undergoing polymerization reactions.
- the supporting polymer may also contain hydrophilic functional groups.
- polymer is used for a molecule comprising two or more repeating units. In particular it may be composed of two or more monomers which may be the same or different. As used herein, the term includes oligomers and prepolymers.
- polymers have a number average weight (M n ) of about 500 g/mol or more, in particular of about 1000 g/mol or more, although the M n may be lower in case the polymer is composed of relatively small monomeric units.
- M n is defined as the M n as determined by light scattering, optionally in combination with Size Exclusion Chromatography (SEC).
- a supporting network can be formed upon curing said supporting polymer.
- the reactive moiety of the supporting polymer may be selected from the group consisting of radically reactive groups, such as alkenes, amino, amido, sulfhydryl (SH), unsaturated esters, such as acrylate and methacrylate, unsaturated ethers, unsaturated amides, and alkyd/dry resins.
- the supporting polymer has a backbone and at least one of the above-mentioned reactive moieties.
- the backbone of the supporting polymer may be selected from the group consisting of polyethers, polyurethanes, polyethylenes, polypropylenes, polyvinyl chlorides, polyepoxides, polyamides, polyacrylamides, poly(meth)acrylics, polyoxazolidones, polyvinyl alcohols, polyethylene imines, polyesters like polyorthoesters and alkyd copolymers, polypeptides, or polysaccharides such as cellulose and starch or any combination of the above.
- polymers with unsaturated esters, amides or ethers, thiol or mercaptan groups may suitably be used in the invention.
- the supporting polymer has a number average molecular weight in the range of about 750 to 20,000 g/mol, more preferably in the range of about 1 ,000 to about 15,000 g/mol, most preferably in the range of about 1 ,100 to about 10,000 g/mol, in particular in the range of about 1 ,200 to about 7,000 g/mol, more in particular in the range of about 1 ,400 to about 5,000 g/mol.
- the advantage of using a relatively high molecular weight supporting polymer, i.e. having molecular weight of more than about 750 g/mol, preferably more than about 1 ,000 g/mol, is that a relatively open supporting network will be formed.
- the average number of reactive groups per molecule of the supporting polymer is preferably in the range of about 1.2 to about 64, more preferably in the range of about 1.2 to about 16, most preferably in the range of about 1.2 to about 8. This means that apart from supporting polymer molecules comprising at least 2 reactive moieties also supporting polymer molecules comprising 1 reactive moiety, i.e. monofunctional polymers, may be present.
- the monofunctional supporting polymers may also be part of the formed supporting network.
- the supporting polymer may be used in more than 1 wt%, for example more than 10 %, more than 20 wt%, more than 30 wt% or more than 40 wt%, based on the total weight of the dry coating.
- the supporting polymer can be present in the hydrophilic coating formulation up to 90 wt%, however, more often the supporting polymer will be used up to 50 or 60 wt%, based on the total weight of the dry coating.
- the hydrophilic coating formulation according to the invention also comprises a polylectrolyte.
- a polyelectrolyte is understood to be a high molecular weight linear, branched or crosslinked polymer composed of macromolecules comprising constitutional units, in which between 5 and 100 % of the constitutional units contain ionized groups when the polyelectrolyte is in the lubricious coating.
- a constitutional unit is understood to be for example a repeating unit, for example a monomer.
- a polyelectrolyte herein may refer to one type of polyelectrolyte composed of one type of macromolecules, but it may also refer to two or more different types of polyelectrolytes composed of different types of macromolecules.
- dry-out time is defined as the duration of the hydrophilic coating remaining lubricious in the open air after the device comprising the hydrophilic coating has been taken out of the wetting fluid wherein it has been stored and/or wetted.
- Hydrophilic coatings with an improved dry- out time i.e. wherein the duration of the hydrophilic coating remaining lubricious is longer, will have a lower tendency of losing water and drying out prior to insertion into the body, or in the body when it comes in contact with e.g. a mucous membrane or vein. This may result in complications when the device comprising the lubricious coating is inserted into the body or removed from the body.
- the dry-out time can be determined by measuring the friction in gram as a function of time the catheter had been exposed to air on the HFT.
- biocompatibility means biological compatibility by not producing a toxic, injurous or immunological response in living mammalian tissue.
- the polyelectrolyte is preferably a polymer having a weight average molecular weight of at least about 1000 g/mol, as determinable by light scattering, optionally in combination with size exclusion chromatography.
- a relatively high molecular weight polyelectrolyte is preferred for increasing the dry-out time and/or reduced migration out of the coating.
- the weight average molecular weight of the polyelectrolyte is preferably at least 20,000 g/mol, more preferably at least 100,000 g/mol, even more preferably at least about 150,000 g/mol, in particular about 200,000 g/mol or more.
- the average weight is 1000,000 g/mol or less, in particular 500,000 g/mol or less, more in particular 300,000 g/mol or less.
- ionized groups that may be present in the polyelectrolyte are ammonium groups, phosphonium groups, sulfonium groups, carboxylate groups, sulfate groups, sulfinic groups, sulfonic groups, phosphate groups, and phosphonic groups. Such groups are very effective in binding water.
- the polyelectrolyte also comprises metal ions. Metal ions, when dissolved in water, are complexed with water molecules to form aqua ions [M(H 2 O ) x ] n+ , wherein x is the coordination number and n the charge of the metal ion, and are therefore particularly effective in binding water.
- Metal ions that may be present in the polyelectrolyte are for example alkali metal ions, such as Na + , Li + , or K + , or alkaline earth metal ions, such as Ca 2+ and Mg 2+ .
- alkali metal ions such as Na + , Li + , or K +
- alkaline earth metal ions such as Ca 2+ and Mg 2+ .
- anions may be present.
- Such anions can for example be halogenides, such as Cl “ , Br “ , I “ and F " , and also sulphates, nitrates, carbonates and phosphates.
- Suitable polyelectrolytes are for example salts of homo- and copolymers of acrylic acid, salts of homo- and co-polymers of methacrylic acid, salts of homo- and co-polymers of maleic acid, salts of homo- and co-polymers of fumaric acid, salts of homo- and co-polymers of monomers comprising sulfonic acid groups, homo- and co-polymers of monomers comprising quarternary ammonium salts and mixtures and/or derivatives thereof.
- poly(acrylamide- co-acrylic acid) salts for example poly(acrylamide-co-acrylic acid) sodium salt, poly(acrylamide-co-methacrylic acid) salts, for example poly(acrylamide-co-methacrylic acid) sodium salt, poly(methacrylamide-co-acrylic acid) salts, for example poly(methacrylamide-co-acrylic acid) sodium salt, poly(methacrylamide-co-methacrylic acid) salts, for example poly(methacrylamide-co-methacrylic acid) sodium salt poly(acrylic acid) salts, for example poly(acrylic acid) sodium salt, poly(methacrylic acid) salts, for example poly(methacrylic acid) sodium salt, poly(acrylic acid-co-maleic acid) salts, for example poly(acrylic acid-co-maleic acid) sodium salt, poly(methacrylic acid-co-maleic acid) salts, for example poly(methacrylic acid-co-maleic acid) sodium salt, for example poly(methacrylic
- Particularly suitable polyelectrolytes for use in the current invention are copolymeric polyelectrolytes, which may be random or block copolymers, wherein said copolymeric polyelectrolyte is a copolymer comprising at least two different types of constitutional units, wherein at least one type of constitutional units comprises ionizable or ionized groups and at least one type of constitutional units is absent of ionizable or ionized groups.
- ionizable is understood to be ionizable in neutral aqueous solutions, i.e. solutions having a pH between 6 and 8.
- An example of such a copolymeric polyelectrolyte is a poly(acrylamide-co-acrylic acid) salt.
- the hydrophilic coating composition according to the invention typically comprises 1-90 wt%, 3-50 wt%, 5-30 wt%, or 10-20 wt% of polyelectrolyte based on the total weight of the dry coating.
- the hydrophilic coating formulation may further comprise a non-ionic hydrophilic polymer.
- a non-ionic hydrophilic polymer is understood to be a high molecular weight linear, branched or cross-linked polymer composed of macromolecules comprising constitutional units, in which less than 5 % of the constitutional units contain ionized groups when the hydrophilic polymer is in the lubricious coating.
- the hydrophilic polymer is capable of providing hydrophilicity to a coating and may be synthetic or bio-derived and can be blends or copolymers of both.
- the hydrophilic polymers include but are not limited to poly(lactams), for example polyvinylpyrollidone (PVP), polyurethanes, homo- and copolymers of acrylic and methacrylic acid, polyvinyl alcohol, polyvinylethers, maleic anhydride based copolymers, polyesters, vinylamines, polyethyleneimines, polyethyleneoxides, poly(carboxylic acids), polyamides, polyanhydrides, polyphosphazenes, cellulosics, for example methyl cellulose, carboxymethyl cellulose, hydroxymethyl cellulose, and hydroxypropylcellulose, heparin, dextran, polypeptides, for example collagens, fibrins, and elastin, polysacharrides, for example chitosan, hyaluronic acid, alginates, ge
- the hydrophilic polymer has a molecular weight in the range of about 8,000 to about 5,000,000 g/mol, preferably in the range of about 20,000 to about 3,000,000 g/mol and more preferably in the range of about 200,000 to about 2,000,000 g/mol.
- the hydrophilic polymer may be used in more than 1 wt%, for example more than 10 wt%, more than 20 wt%, or more than 30 weight %, based on the total weight of the dry coating.
- the hydrophilic polymer can be present up to 95 wt%, however, more often the hydrophilic polymer will be used up to 50, 60, 70 or 80 wt%, based on the total weight of the dry coating.
- the weight ratio of the total weight of polyelectrolyte and hydrophilic polymer to supporting polymer may for example vary between 10 : 90 and 90 : 10, such as between 25 : 75 and 75: 25 or such as between 60 : 40 and 40 : 60.
- the invention relates to a hydrophilic coating formulation which when applied to a substrate and cured results in a hydrophilic coating.
- a hydrophilic coating formulation refers to a liquid hydrophilic coating formulation, e.g. a solution or a dispersion comprising a liquid medium.
- any liquid medium that allows application of the hydrophilic coating formulation on a surface would suffice.
- liquid media examples include alcohols, like methanol, ethanol, propanol, butanol or respective isomers and aqueous mixtures thereof, acetone, methylethyl ketone, tetrahydrofuran, dichloromethane, toluene, and aqueous mixtures or emulsions thereof or water.
- the hydrophilic coating formulation further comprises components which when cured are converted into the hydrophilic coating, and thus remain in the hydrophilic coating after curing.
- curing is understood to refer to physical or chemical hardening or solidifying by any method, for example heating, cooling, drying, crystallization or curing as a result of a chemical reaction, such as radiation-curing or heat-curing.
- all or part of the components in the hydrophilic coating formulation may be cross- linked forming covalent linkages between all or part of the components, for example by using UV or electron beam radiation.
- all or part of the components may also be ionically bonded, bonded by dipole-dipole type interactions, or bonded via Van der Waals forces or hydrogen bonds.
- to cure includes any way of treating the formulation such that it forms a firm or solid coating.
- the term includes a treatment whereby the hydrophilic polymer further polymerizes, is provided with grafts such that it forms a graft polymer and/or is cross-linked, such that it forms a cross-linked polymer.
- the invention also relates to a hydrophilic coating obtainable by applying the hydrophilic coating formulation according to the invention to a substrate and curing it.
- the invention further relates to a lubricious coating obtainable by applying a wetting fluid to said hydrophilic coating, and to the use of a Norrish Type I and a Norrish Type Il photo-initiator in a lubricious coating in order to improve its wear resistance.
- the invention relates to an article, in particular a medical device or a medical device component comprising at least one hydrophilic coating according to the invention and to a method of forming on a substrate the hydrophilic coating according to the invention.
- the hydrophilic coating comprises a polyelectrolyte, optionally a hydrophilic polymer, and a supporting network, which may be a hydrophilic supporting network, and which is formed from the supporting polymer.
- Said hydrophilic coating is formed by curing a hydrophilic coating formulation comprising the polyelectrolyte, optionally the hydrophilic polymer, the supporting polymer, the Norrish Type I photoinitiator and the Norrish Type Il photoinitiator.
- the polyelectrolyte and/or the supporting network are covalently linked and/or physically bound to each other and/or entrapped to form a polymer network after curing. If a hydrophilic polymer is present this may also be covalently linked and/or physically bound to one or more of the other components and/or entrapped to form a polymer network after curing.
- polyelectrolyte, optionally the hydrophilic polymer and/or the supporting polymer are covalently and/or physically bound in the hydrophilic coating as part of a polymer network
- polyelectrolyte and the hydrophilic polymer if present will not leak out into the environment of the hydrophilic coating, for example when it is coated on a medical device. This is particularly useful when the medical device is inside the human or animal body.
- a polyelectrolyte is present in a wetting fluid and introduced into the hydrophilic coating when wetting the hydrophilic coating according to the invention.
- This is particularly useful for medical devices with a hydrophilic coating which are packed in a fluid, or wherein the hydrophilic coating is wetted in a separate wetting fluid that contains the polyelectrolyte.
- the invention therefore also relates to coating system for preparing a lubricious coating, said coating system comprising the coating formulation according to the invention and a wetting fluid comprising a polyelectrolyte.
- the hydrophilic coating formulation according to the invention further comprises at least one surfactant, which can improve the surface properties of the coating.
- Surfactants constitute the most important group of detergent components. Generally, these are water-soluble surface- active agents comprised of a hydrophobic portion, usually a long alkyl chain, attached to hydrophilic or water solubility enhancing functional groups. Surfactants can be categorized according to the charge present in the hydrophilic portion of the molecule (after dissociation in aqueous solution): ionic surfactants, for example anionic or cationic surfactants, and non-ionic surfactants.
- ionic surfactants include Sodium dodecylsulfate (SDS), Sodium cholate, Bis(2-ethylhexyl)sulfosuccinate Sodium salt, Cetyltrimethylammoniumbromide (CTAB), Lauryldimethylamine-oxide (LDAO), N- Lauroylsarcosine Sodium salt and Sodium deoxycholate (DOC).
- SDS sodium dodecylsulfate
- cholate Bis(2-ethylhexyl)sulfosuccinate Sodium salt
- CAB Cetyltrimethylammoniumbromide
- LDAO Lauryldimethylamine-oxide
- DOC N- Lauroylsarcosine Sodium salt
- DOC Sodium deoxycholate
- non-ionic surfactants include Alkyl Polyglucosides such as TRITONTM BG-10 Surfactant and TRITON CG-110 Surfactant, Branched Secondary Alcohol Ethoxylates such as TERGITOLTM TMN Series, Ethylene Oxide / Propylene Oxide Copolymers, such as TERGITOL L Series, and TERGITOL XD, XH, and XJ Surfactants, Nonylphenol
- Ethoxylates such as TERGITOL NP Series, Octylphenol Ethoxylates, such as TRITON X Series, Secondary Alcohol Ethoxylates, such as TERGITOL 15-S Series and Specialty Alkoxylates, such as TRITON CA Surfactant, TRITON N-57 Surfactant, TRITON X-207 Surfactant, Tween 80 and Tween 20.
- TRITON CA Surfactant TRITON N-57 Surfactant
- TRITON X-207 Surfactant TRITON X-207 Surfactant
- Tween 80 and Tween 20 typically 0.001 to 1 wt% of surfactant can be applied, preferably 0.05-0.5 wt%, based on the total weight of the dry coating.
- the hydrophilic coating formulation according to the invention further comprises at least one plasticizing agent, which can enhance the flexibility of the coating, which may be preferable when the object to be coated is likely to bend during use.
- Said plasticizing agent may be included in the hydrophilic coating formulation in a concentration of from about 0.01 wt% to about 15 wt% based on the total weight of the dry coating, preferably from about 1 wt% to about 5.0 wt%.
- Suitable plasticizers are high boiling compounds, preferably with a boiling point at atmospheric pressure of >200 0 C, and with a tendency to remain homogeneously dissolved and/or dispersed in the coating after cure.
- plasticizers are mono- and polyalcohols and polyethers, such as decanol, glycerol, ethylene glycol, diethylene glycol, polyethylene glycol and/or copolymers with propylene glycol and/or fatty acids.
- the hydrophilic coating according to the invention can be coated on an article.
- the hydrophilic coating can be coated on a substrate which may be selected from a range of geometries and materials.
- the substrate may have a texture, such as porous, non-porous, smooth, rough, even or uneven.
- the substrate supports the hydrophilic coating on its surface.
- the hydrophilic coating can be on all areas of the substrate or on selected areas.
- the hydrophilic coating can be applied to a variety of physical forms, including films, sheets, rods, tubes, molded parts (regular or irregular shape), fibers, fabrics, and particulates.
- Suitable surfaces for use in the invention are surfaces that provide the desired properties such as porosity, hydrophobicity, hydrophilicity, colorisability, strength, flexibility, permeability, elongation abrasion resistance and tear resistance.
- suitable surfaces are for instance surfaces that consist of or comprise metals, plastics, ceramics, glass and/or composites.
- the hydrophilic coating may be applied directly to the said surfaces or may be applied to a pretreated or coated surface where the pretreatment or coating is designed to aid adhesion of the hydrophilic coating to the substrate.
- the hydrophilic coating according to the invention is coated on a biomedical substrate.
- a biomedical substrate refers, in part, to the fields of medicine, and the study of living cells and systems. These fields include diagnostic, therapeutic, and experimental human medicine, veterinary medicine, and agriculture. Examples of medical fields include ophthalmology, orthopedics, and prosthetics, immunology, dermatology, pharmacology, and surgery; nonlimiting examples of research fields include cell biology, microbiology, and chemistry.
- biomedical also relates to chemicals and compositions of chemicals, regardless of their source, that (i) mediate a biological response in vivo, (ii) are active in an in vitro assay or other model, e.g., an immunological or pharmacological assay, or (iii) can be found within a cell or organism.
- biomedical also refers to the separation sciences, such as those involving processes of chromatography, osmosis, reverse osmosis, and filtration. Examples of biomedical articles include research tools, industrial, and consumer applications. Biomedical articles include separation articles, implantable articles, and ophthalmic articles.
- Ophthalmic articles include soft and hard contact lenses, intraocular lenses, and forceps, retractors, or other surgical tools that contact the eye or surrounding tissue.
- a preferred biomedical article is a soft contact lens made of a silicon-containing hydrogel polymer that is highly permeable to oxygen.
- Separation articles include filters, osmosis and reverse osmosis membranes, and dialysis membranes, as well as bio-surfaces such as artificial skins or other membranes.
- Implantable articles include catheters, and segments of artificial bone, joints, or cartilage.
- An article may be in more than one category, for example, an artificial skin is a porous, biomedical article.
- Examples of cell culture articles are glass beakers, plastic petri dishes, and other implements used in tissue cell culture or cell culture processes.
- a preferred example of a cell culture article is a bioreactor micro-carrier, a silicone polymer matrix used in immobilized cell bioreactors, where the geometry, porosity, and density of the particulate micro-carrier may be controlled to optimize performance.
- the micro-carrier is resistant to chemical or biological degradation, to high impact stress, to mechanical stress (stirring), and to repeated steam or chemical sterilization.
- silicone polymers other materials may also be suitable.
- This invention may also be applied in the food industry, the paper printing industry, hospital supplies, diapers and other liners, and other areas where hydrophilic, wettable, or wicking articles are desired.
- the medical device can be an implantable device or an extracorporeal device.
- the devices can be of short-term temporary use or of long-term permanent implantation.
- suitable devices are those that are typically used to provide for medical therapy and/or diagnostics in heart rhythm disorders, heart failure, valve disease, vascular disease, diabetes, neurological diseases and disorders, orthopedics, neurosurgery, oncology, ophthalmology, and ENT surgery.
- Suitable examples of medical devices include, but are not limited to, a stent, stent graft, anastomotic connector, synthetic patch, lead, electrode, needle, guide wire, catheter, sensor, surgical instrument, angioplasty balloon, wound drain, shunt, tubing, infusion sleeve, urethral insert, pellet, implant, blood oxygenator, pump, vascular graft, vascular access port, heart valve, annuloplasty ring, suture, surgical clip, surgical staple, pacemaker, implantable defibrillator, neurostimulator, orthopedic device, cerebrospinal fluid shunt, implantable drug pump, spinal cage, artificial disc, replacement device for nucleus pulposus, ear tube, intraocular lens and any tubing used in minimally invasive surgery.
- Articles that are particularly suited to be used in the present invention include medical devices or components such as catheters, for example intermittent catheters, balloon catheters, PTCP catheters, stent delivery catheters, guide wires, stents, syringes, metal and plastic implants, contact lenses and medical tubing.
- catheters for example intermittent catheters, balloon catheters, PTCP catheters, stent delivery catheters, guide wires, stents, syringes, metal and plastic implants, contact lenses and medical tubing.
- the hydrophilic coating formulation can be applied to the substrate by for example dip-coating. Other methods of application include spray, wash, vapor deposition, brush, roller and other methods known in the art.
- concentration of ionic or ionizable groups in the hydrophilic coating and the thickness of the hydrophilic coating according to the invention may be controlled by altering the type of polyelectrolyte, polyelectrolyte concentration in the hydrophilic coating formulation, soaking time, drawing speed, viscosity of the hydrophilic coating formulation and the number of coating steps.
- the thickness of a hydrophilic coating on a substrate ranges from 0.1-300 ⁇ m, preferably 0.5-100 ⁇ m, more preferably 1-30 ⁇ m.
- the invention further relates to a method of forming on a substrate a hydrophilic coating which has a low coefficient of friction when wetted with a water- based liquid, wherein said hydrophilic coating comprises an polyelectrolyte.
- a primer coating may be used in order to provide a binding between the hydrophilic coating and the substrate.
- the primer coating is often referred to as the primary coating, base coat or tie coat.
- Said primer coating is a coating that facilitates adhesion of the hydrophilic coating to a given substrate, as is described in for example WO02/10059.
- primer coatings may be solvent based, water based (latexes or emulsions) or solvent free and may comprise linear, branched and/or cross-linked components.
- Typical primer coatings that could be used comprise for example polyether sulfones, polyurethanes, polyesters, including polyacrylates, as described in for example US6,287,285, polyamides, polyethers, polyolefins and copolymers of the mentioned polymers.
- the primer coating comprises a supporting polymer network, the supporting network optionally comprising a functional hydrophilic polymer entangled in the supporting polymer network as described in WO2006/056482 A1.
- the information with respect to the formulation of the primer coating is herewith incorporated by reference.
- a primer coating as described above is in particular useful for improving adherence of a coating comprising a hydrophilic polymer such as a polylactam, in particular PVP and/or another of the above identified hydrophilic polymers, in particular on polyvinylchloride (PVC), silicone, polyamide, polyester, polyolefin, such as polyethylene, polypropylene and ethylene-propylene rubber (e.g. EPDM), or a surface having about the same or a lower hydrophilicity.
- a hydrophilic polymer such as a polylactam, in particular PVP and/or another of the above identified hydrophilic polymers, in particular on polyvinylchloride (PVC), silicone, polyamide, polyester, polyolefin, such as polyethylene, polypropylene and ethylene-propylene rubber (e.g. EPDM), or a surface having about the same or a lower hydrophilicity.
- the thickness of the primer coating typically the thickness is less than 5 ⁇ m, less than 2 ⁇ m or less than 1 ⁇ m.
- the surface of the article is subjected to oxidative, photo-oxidative and/or polarizing surface treatment, for example plasma and/or corona treatment in order to improve the adherence of the coating which is to be provided.
- oxidative, photo-oxidative and/or polarizing surface treatment for example plasma and/or corona treatment
- Suitable conditions are known in the art.
- Application of the formulation of the invention may be done in any manner. Curing conditions can be determined, based on known curing conditions for the photo-initiator and polymer or routinely be determined.
- curing may be carried out at any suitable temperature depending on the substrate, as long as the mechanical properties or another property of the article are not adversely affected to an unacceptable extent.
- Intensity and wavelength of the electromagnetic radiation can routinely be chosen based on the photoinitiator of choice.
- a suitable wavelength in the UV, visible or IR part of the spectrum may be used.
- a primer coating formulation was prepared as indicated below.
- the above primer coating formulation was applied to Pebax ® 7233 catheter tubing (shafts) with an outer diameter of 0.034" (0.86mm) using a Harland 175-24 PCX coater.
- the application parameters were used as listed in Table 1.
- toluene diisocyanate (TDI or T, Aldrich, 95% purity, 87.1 g, 0.5 mol), Irganox 1035 (Ciba Specialty Chemicals, 0.58 g, 1 wt% relative to hydroxy ethyl acrylate (HEA or H)) and tin(ll) 2-ethyl hexanoate (Sigma, 95% purity, 0.2 g, 0.5 mol) were placed in a 1 liter flask and stirred for 30 minutes. The reaction mixture was cooled to 0 0 C using an ice bath.
- a hydrophilic coating formulation (1 ) was prepared comprising both a Norrish Type I (Irgacure 2959) and a Norrish Type Il (benzophenone) photoinitiator.
- hydrophilic coating formulation A was prepared without Norrish Type Il photoinitiator.
- Example 1 and Comparative Experiment A were added to brown colored glass flasks and mixed overnight (-16 hours) at room temperature. The next morning the hydrophilic coating formulations were homogeneous liquids with a viscosity as indicated in Table 2. Herein the viscosity was measured on a Brookfield CAP1000, v.1.2 in combination with cone nr. 1 at 25 0 C. Svnthesis of PEG4000DA
- the reaction mixture was stirred for 2 to 4 h at 45 0 C under nitrogen atmosphere. During the reaction the temperature was kept at 45 0 C to prevent crystallization of PEG. To determine the conversion a sample was withdrawn from the reaction mixture, dried and dissolved in deuterated chloroform. Trifluoro acetic anhydride (TFAA) was added and a 1 H-NMR spectrum was recorded.
- TFAA Trifluoro acetic anhydride
- TFAA reacts with any remaining hydroxyl groups to form a trifluoro acetic ester, which can be easily detected using 1 H-NMR spectroscopy (the triplet signal of the methylene protons in the ⁇ -position of the trifluoro acetic acid group (g, 4.45 ppm) can be clearly distinguished from the signal of the methylene groups in the ⁇ -position of the acrylate ester (d, 4.3 ppm)).
- the triplet signal of the methylene protons in the ⁇ -position of the trifluoro acetic acid group g, 4.45 ppm
- the signal of the methylene groups in the ⁇ -position of the acrylate ester d, 4.3 ppm
- Example 1 At a degree of acrylate esterification higher than 98 % the warm solution was filtered to remove triethylamine hydrochloride salts. Approximately 300 ml of toluene was removed under vacuum (50 0 C, 20 mbar). The remaining solution was kept at 45 0 C in a heated dropping funnel and added dropwise to 1 liter of diethyl ether (cooled in an ice bath). The ether suspension was cooled for 1 h before PEG4000DA was obtained by filtration. The product was dried overnight at room temperature under reduced air atmosphere (300 mbar). Yield: 80-90 % as white crystals.
- the hydrophilic coating formulations of Example 1 and Comparative Experiment A were applied on the Pebax® 7233 shafts with primer coating using a Harland 175-24 PCX coater. The relevant application conditions used are represented in Table 2.
- the coated length of the Pebax catheter shafts was 27 cm for the primer coating and the hydrophilic coating.
- the UV light intensity in the PCX coater is 60 mW/cm 2 between 250-400nm, measured with a Harland UVR335 (IL1400) light meter in combination with detector SED005#989 and filter WBS320#27794.
- the primer coating was exposed 15 seconds, while the topcoat was exposed 360 seconds to the UV light. This correspondings with a UV-dose of respectively 0.9 J/cm 2 and 21.6 J/cm 2 .
- the temperature was 21 0 C and 50% RH.
- Table 3 For applied coating parameters see Table 3.
- coated catheter shafts were tested in a particulate release test as described below.
- Particulates release wear test The particulates release wear test was conducted on a Zwick 1474
- Zwick tensile tester with 10N KAP-Z loadcell (hereinafter referred to as "Zwick tensile tester", see Figure 1 ).
- Zwick tensile tester see Figure 1 .
- the following materials and set-up were used:
- Nitinol SE metal guide wire (diameter 0.0022", New England Precision Grinding) as reinforcing core wire inside each coated catheter shaft.
- Pro-Flo guiding catheter 625 mm top-part of Medtronic Pro-Flo 6F pigtail 2.00 mm, 110 cm, cardiovascular angiographic catheter (hereinafter referred to as "Pro-Flo guiding catheter” or, in Figure 1 , “Pro-Flo guiding catheter”) as outer counter surface for the wear test.
- the connector on the proximal end was used to connect a syringe.
- the mould has a 180 0 C curvature of 040mm
- coated catheter shaft in Figure 1 : "colored CV catheter shaft" as described above.
- the coated catheter shaft was glued onto the Nitinol guide wire using Loctite, to prevent sliding of the coated catheter shaft during testing, 200 mm from the end of the Nitinol guide wire (from the load cell). This ensured that the coated catheter shaft was placed just before entering the 0 40 mm curvature when inserting into the test set-up (see Figure 1 ).
- the coated catheter shaft was placed in milli-Q water for 30 seconds to ensure proper wetting of the hydrophilic coating. During wetting of the sample for 30 seconds, the Congo-red indicator partly dissolved in the water.
- the Nitinol guide wire and the glued coated catheter shaft were inserted into the straightened and pre-wetted Pro-Flo guiding catheter, at the catheter entrance part.
- the Pro-Flo guiding catheter and the inserted coated catheter shaft were placed in the polymer supporting mould, with the specific 180 ° curvature of 40 mm, and extra milli-Q water was carefully flushed into the Pro-Flo guiding catheter to ensure complete wetting of the inner space.
- the polymer mould and Pro-Flo guiding catheter comprising the inserted coated catheter shaft were placed into the Zwick tensile tester and attached to the load cell by a clamp, which was placed 350 mm above the top of the mould.
- the end part of the catheter shaft was now inside the Pro-Flo guiding catheter just before entering the curvature where friction (and wear) mainly takes place.
- the coated catheter shaft was inserted over a length of 100 mm and withdrawn over the same length with a speed of 200 mm/min. One insertion and withdrawal is defined as 1 cycle. Each sample was conducted to the test during 5 cycles.
- one side of the Pro-Flo guiding catheter was released from the mould and placed above a jar collecting the milli-Q water out of the Pro-Flo guiding catheter.
- a syringe, containing 10 ml of milli-Q water was attached to the catheter entrance part of the Pro-Flo guiding catheter, flushing the Pro-Flo guiding catheter.
- the Nitinol guide wire and attached coated catheter shaft were removed and flushed with 10ml of milli-Q water.
- the Pro- Flo guiding catheter was flushed with 4x 10ml of milli-Q water.
- the 60 ml of collected milli-Q water was subjected to particulates measurements (see below), while the Pro- Flo guiding catheter was dried for further visual check of contamination with coloured particles. No particles were found.
- a 0.45-micron filter Millipore type HAWP was used to filtrate the collected milli-Q water solution. With this filter also particles smaller than 10 micron are collected, while such small particles do not need to be included in the counting according to the USP28 standard. However, the image analysis as described below could clearly distinguish between sizes bigger and smaller than 10 micron.
- a Millipore glass B ⁇ chner funnel system was used for this procedure.
- the filter was wetted with pure water first to make sure the filter did not colour red too much. A slightly pink colour could not be prevented. This background colour was corrected with the white and colour balance. This correction did not affect the final result.
- Microscopy images were recorded using a LEICA MA FLIII equipped with a CC-12 Soft Imaging System.
- the filter was illuminated in 180 ° backscattering mode with a LEICA CLS 150X with light guides fixed to the microscope.
- the upper switch was set on value 4 and the lower was set at position 6.
- a 10x ocular was used and the zoom factor was 5.
- the white balance was auto set using white paper.
- the illumination time per photo capture was set at 3.900 ms.
- the filter was partially imaged with 9 photos in total representing an area of 2.71 x 2.12 mm equals 5.7 mm 2 each.
- a piece of paper with a grid of 9 sections was placed under the filter enabling to record images out of every section.
- the total filter surface is 1020 mm 2 .
- the image analysis comprised the following steps: - Background subtraction
- fTotal[[1 , 1 ]] Table[ ⁇ Abs[(fMain[[1 , 1 ,i,j,3]]-(r ⁇ +r1 * i+r2 * i ⁇ 2+r3 * j+r4 * j ⁇ 2)-10) * 2-40],0,0 ⁇ , ⁇ i,n1 ⁇ , ⁇ j,n2 ⁇ ];
- the resulting picture was saved as a JPG file.
- the image was then opened in Bersoft imaging software to detect all objects which had a RGB Red pixel value above 24.
- the level was chosen such that it is just above the remaining overall background value.
- the data was exported to Excel wherein the visualization is done. The result of all nine images was put together and corrected for the fraction of the total filter surface.
- Particles were analysed on the filter. Particles which were smaller than 10 micron in all directions were ignored according to the USP28. Particles which were larger than 10 micron in at least one direction were counted and related to the USP28 standard. Particle surfaces were converted to particle volumes, assuming that the particles were rigid spheres. It was taken into account that the catheter has a coating thickness of 2 micron. Criteria:
- Particles > 10 micron (particle volume between 500 ⁇ m 3 and 8000 ⁇ m 3 ): less than 3000 per release test ( per filter).
- Particles > 25 micron (particle volume > 8000 ⁇ m 3 ): less than 300 per release test ( per filter).
- the hydrophilic coatings 1 and A on the catheter shafts were both subjected to the particulates release wear test as described above.
- the particulates release of these two coatings is represented in Table 4.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Paints Or Removers (AREA)
- Materials For Medical Uses (AREA)
- Polymerisation Methods In General (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Polyethers (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2009009145A MX2009009145A (en) | 2007-02-28 | 2008-02-27 | Hydrophilic coating. |
CN200880006517.4A CN101622019B (en) | 2007-02-28 | 2008-02-27 | Hydrophilic coating |
EP08717201A EP2125061A2 (en) | 2007-02-28 | 2008-02-27 | Hydrophilic coating |
US12/528,123 US8513320B2 (en) | 2007-02-28 | 2008-02-27 | Hydrophilic coating |
JP2009551201A JP5587612B2 (en) | 2007-02-28 | 2008-02-27 | Hydrophilic coating |
BRPI0808118-2A2A BRPI0808118A2 (en) | 2007-02-28 | 2008-02-27 | HYDROPHILIC COATING |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07004100 | 2007-02-28 | ||
EP07004100.9 | 2007-02-28 | ||
US90760807P | 2007-04-11 | 2007-04-11 | |
US60/907,608 | 2007-04-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008104573A2 true WO2008104573A2 (en) | 2008-09-04 |
WO2008104573A3 WO2008104573A3 (en) | 2009-03-19 |
Family
ID=38474357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/052397 WO2008104573A2 (en) | 2007-02-28 | 2008-02-27 | Hydrophilic coating |
Country Status (8)
Country | Link |
---|---|
US (1) | US8513320B2 (en) |
EP (1) | EP2125061A2 (en) |
JP (1) | JP5587612B2 (en) |
CN (1) | CN101622019B (en) |
BR (1) | BRPI0808118A2 (en) |
MX (1) | MX2009009145A (en) |
MY (1) | MY148410A (en) |
WO (1) | WO2008104573A2 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010079229A1 (en) | 2009-01-09 | 2010-07-15 | Dsm Ip Assets B.V. | Primer for coating coiled wires |
JP2012502690A (en) * | 2008-09-15 | 2012-02-02 | シーヴィー インジェニュイティ コーポレイション | Local delivery of water-soluble or water-insoluble therapeutic agents to the body lumen surface |
JP2013520277A (en) * | 2010-02-24 | 2013-06-06 | シーヴィー インジェニュイティ コーポレイション | Local delivery of water-soluble or water-insoluble therapeutic agents to the body lumen surface |
US8512795B2 (en) | 2005-12-09 | 2013-08-20 | Dsm Ip Assets B.V. | Hydrophilic coating comprising a polyelectrolyte |
US8513320B2 (en) | 2007-02-28 | 2013-08-20 | Dsm Ip Assets B.V. | Hydrophilic coating |
WO2014107670A1 (en) * | 2013-01-04 | 2014-07-10 | Surmodics, Inc. | Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers |
US8809411B2 (en) | 2007-02-28 | 2014-08-19 | Dsm Ip Assets B.V. | Hydrophilic coating |
US8957125B2 (en) | 2010-06-16 | 2015-02-17 | Dsm Ip Assets B.V. | Coating formulation for preparing a hydrophilic coating |
US9034362B2 (en) | 2008-09-15 | 2015-05-19 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9132211B2 (en) | 2008-09-15 | 2015-09-15 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
WO2016200337A1 (en) | 2015-06-08 | 2016-12-15 | Jmedtech Pte Ltd | Coating compositions comprising adhesion promoting base layer |
US9737637B2 (en) | 2004-11-29 | 2017-08-22 | Dsm Ip Assets B.V. | Method for reducing the amount of migrateables of polymer coatings |
WO2017173114A1 (en) * | 2016-03-31 | 2017-10-05 | Surmodics, Inc. | Lubricious coating for medical device |
US20170304506A1 (en) * | 2012-01-18 | 2017-10-26 | Surmodics, Inc. | Lubricious medical device coating with low particulates |
US9956385B2 (en) | 2012-06-28 | 2018-05-01 | The Spectranetics Corporation | Post-processing of a medical device to control morphology and mechanical properties |
CN108159495A (en) * | 2017-12-30 | 2018-06-15 | 深圳市拓普生物科技有限公司 | 3D bioproteins and its preparation method and application |
US10124088B2 (en) | 2014-09-29 | 2018-11-13 | Surmodics, Inc. | Lubricious medical device elements |
US10342898B2 (en) | 2015-12-29 | 2019-07-09 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US10525171B2 (en) | 2014-01-24 | 2020-01-07 | The Spectranetics Corporation | Coatings for medical devices |
CN112795300A (en) * | 2020-12-30 | 2021-05-14 | 邦弗特新材料股份有限公司 | UV coating and preparation method thereof |
US11123459B2 (en) | 2016-12-16 | 2021-09-21 | Surmodics, Inc. | Hydrophobic active agent particle coatings and methods for treatment |
US11174447B2 (en) | 2015-12-29 | 2021-11-16 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US11744925B2 (en) | 2019-01-28 | 2023-09-05 | Microvention, Inc. | Coatings |
US11850370B2 (en) | 2014-08-26 | 2023-12-26 | C. R. Bard, Inc. | Urinary catheter |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008031601A1 (en) * | 2006-09-13 | 2008-03-20 | Dsm Ip Assets B.V. | Antimicrobial hydrophilic coating comprising metallic silver particles |
US20100076546A1 (en) * | 2006-09-13 | 2010-03-25 | Dsm Ip Assets B.V. | Coating formulation for medical coating |
US20110059874A1 (en) * | 2008-03-12 | 2011-03-10 | Marnix Rooijmans | Hydrophilic coating |
SG175373A1 (en) | 2009-04-28 | 2011-11-28 | Surmodics Inc | Devices and methods for delivery of bioactive agents |
US8999264B2 (en) | 2010-09-29 | 2015-04-07 | Siemens Healthcare Diagnostics Inc. | Hydrophilic coating for nonporous surfaces and microfluidic devices including same |
JP2012241127A (en) * | 2011-05-20 | 2012-12-10 | Hitachi Chemical Co Ltd | Photocurable resin composition, and photocurable resin composition varnish and photocurable resin composition cured product using the same |
US10213529B2 (en) | 2011-05-20 | 2019-02-26 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
US9757497B2 (en) | 2011-05-20 | 2017-09-12 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
US9861727B2 (en) | 2011-05-20 | 2018-01-09 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
US20140335610A1 (en) * | 2011-11-20 | 2014-11-13 | Tokyo Women's Medical University | Cell culture substrate, and method for manufacturing same |
US8956682B2 (en) | 2012-04-02 | 2015-02-17 | Surmodics, Inc. | Hydrophilic polymeric coatings for medical articles with visualization moiety |
WO2014004997A1 (en) | 2012-06-29 | 2014-01-03 | Surmodics, Inc. | Cell attachment coatings and methods using phosphorous-containing photoreagent |
US9395468B2 (en) * | 2012-08-27 | 2016-07-19 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
US11246963B2 (en) | 2012-11-05 | 2022-02-15 | Surmodics, Inc. | Compositions and methods for delivery of hydrophobic active agents |
CA2890205C (en) | 2012-11-05 | 2020-12-22 | Surmodics, Inc. | Composition and method for delivery of hydrophobic active agents |
JP6053482B2 (en) * | 2012-11-30 | 2016-12-27 | 住友ゴム工業株式会社 | Manufacturing method of gasket for syringe |
CN102973987B (en) * | 2012-12-10 | 2014-03-12 | 宁波保税区安杰脉德医疗器械有限公司 | Medical hydrophilic lubrication coating of water system and preparation method thereof |
US9629945B2 (en) | 2012-12-12 | 2017-04-25 | Surmodics, Inc. | Stilbene-based reactive compounds, polymeric matrices formed therefrom, and articles visualizable by fluorescence |
HK1218396A1 (en) * | 2013-02-04 | 2017-02-17 | Gore & Ass | Coating for substrate |
US9533262B2 (en) | 2013-03-14 | 2017-01-03 | Dow Global Technologies Llc | Composite polyamide membrane including dissolvable polymer coating |
WO2015012804A2 (en) * | 2013-07-23 | 2015-01-29 | Empire Technology Development Llc | Photo-activated hydrophilic coatings and methods for their preparation and use |
EP3069195B8 (en) | 2013-11-15 | 2019-07-10 | Tangible Science, LLC | Contact lens with a hydrophilic layer |
US20150151500A1 (en) * | 2013-12-03 | 2015-06-04 | Johnson & Johnson Vision Care, Inc. | Method for treating a contact lens mold |
CN107206119B (en) | 2014-12-09 | 2021-01-29 | 实体科学公司 | Medical device coating with biocompatible layer |
CN107405424A (en) | 2015-01-29 | 2017-11-28 | 苏尔莫迪克斯公司 | The delivering of hydrophobic active agent particle |
LT3283136T (en) | 2015-04-16 | 2021-06-25 | Hollister Incorporated | Hydrophilic coatings and methods of forming the same |
US10478546B2 (en) | 2015-09-15 | 2019-11-19 | Surmodics, Inc. | Hemodialysis catheter sleeve |
CN108137841B (en) * | 2015-09-30 | 2021-07-06 | 3M创新有限公司 | Hydrogel compositions bonded to polymeric substrates |
US10806904B2 (en) | 2016-03-31 | 2020-10-20 | Surmodics, Inc. | Two-part insertion tool and methods |
US10918835B2 (en) | 2016-03-31 | 2021-02-16 | Surmodics, Inc. | Delivery system for active agent coated balloon |
US20170281914A1 (en) | 2016-03-31 | 2017-10-05 | Surmodics, Inc. | Localized treatment of tissues through transcatheter delivery of active agents |
US10391292B2 (en) | 2016-06-15 | 2019-08-27 | Surmodics, Inc. | Hemostasis sealing device with constriction ring |
CN107754017B (en) * | 2016-08-22 | 2021-06-04 | 上海微创医疗器械(集团)有限公司 | Coating for medical instrument surface and application |
CN110198756B (en) | 2016-09-16 | 2022-07-12 | 舒尔默迪克斯公司 | Lubricious insertion tool for medical devices and methods of using same |
US10758719B2 (en) | 2016-12-15 | 2020-09-01 | Surmodics, Inc. | Low-friction sealing devices |
US10898446B2 (en) | 2016-12-20 | 2021-01-26 | Surmodics, Inc. | Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces |
JP7150744B2 (en) * | 2017-03-29 | 2022-10-11 | スリーエム イノベイティブ プロパティズ カンパニー | Hydrogel composition bound to a polymer matrix |
CN109535284B (en) | 2017-07-31 | 2021-07-06 | 广东华润涂料有限公司 | Photoinitiator composition suitable for UV-LED light radiation and water-based coating composition prepared from same |
WO2019222335A1 (en) | 2018-05-16 | 2019-11-21 | Surmodics, Inc. | High-pressure balloon catheters and methods |
US20190351198A1 (en) | 2018-05-16 | 2019-11-21 | Surmodics, Inc. | Catheters with structurally supported expandable elements and methods for same |
CN111514378B (en) * | 2019-02-02 | 2021-03-09 | 江苏百赛飞生物科技有限公司 | Central venous catheter, preparation method thereof and medical device comprising same |
IL266050B (en) | 2019-04-15 | 2021-03-25 | Israel Plastics And Rubber Center Ltd | A lubricious, therapeutic and abrasion-resistant coating for devices and methods for producing and using thereof |
CN114173838A (en) * | 2019-07-26 | 2022-03-11 | 微仙美国有限公司 | Coating material |
KR102332714B1 (en) * | 2019-11-07 | 2021-12-02 | 울산대학교 산학협력단 | Ventilation tube insertable into tympanic membrane |
KR20230078950A (en) * | 2020-09-30 | 2023-06-05 | 세키스이가가쿠 고교가부시키가이샤 | Thioxanthone compound, photopolymerization initiator, curable resin composition, display element composition, liquid crystal display element sealant, upper and lower conduction material, and liquid crystal display element |
KR102472557B1 (en) * | 2021-01-21 | 2022-11-29 | 연세대학교 산학협력단 | Neuromorphic device based on memristor having biodegradability and method of manufacturing thereof |
CN113354993A (en) * | 2021-07-15 | 2021-09-07 | 乐普(北京)医疗器械股份有限公司 | Hydrophilic coating, preparation method and coating firmness testing method |
EP4423198A1 (en) * | 2021-11-18 | 2024-09-04 | Aculon, Inc. | Coated substrates that demonstrate superhydrophilicity, suitable for use as medical devices |
US20230285641A1 (en) | 2022-03-09 | 2023-09-14 | Surmodics Coatings, LLC | Thromboresistant coatings, coated devices, and methods |
WO2023211937A1 (en) | 2022-04-25 | 2023-11-02 | Surmodics, Inc. | Medical device coatings with microcrystalline active agents |
US20240240098A1 (en) | 2022-11-10 | 2024-07-18 | Surmodics, Inc. | Polyacrylic acid containing lubricious coatings for medical devices with enhanced properties |
WO2024148271A1 (en) | 2023-01-05 | 2024-07-11 | Surmodics, Inc. | Lubricious coatings for medical devices with enhanced durability |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5005287A (en) * | 1987-05-06 | 1991-04-09 | Wilkinson Sword Gmbh | Process for making a hydrophilic coating on a formed part and safety razor made using this process |
EP1065738A1 (en) * | 1999-06-28 | 2001-01-03 | Samhwa Paints Ind. Co., Ltd. | Coating material for shielding electromagnetic waves |
US20020002353A1 (en) * | 1998-01-30 | 2002-01-03 | Advanced Cardiovascular Systems, Inc. | Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device |
US20040135967A1 (en) * | 2002-12-03 | 2004-07-15 | Carney Fiona Patricia | Medical devices having antimicrobial coatings thereon |
US20050170071A1 (en) * | 2004-01-29 | 2005-08-04 | Scimed Life Systems, Inc. | Lubricious composition |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU494547B2 (en) * | 1972-07-10 | 1977-10-20 | Johnson & Johnson | Hydrophilic random interpolymer compositions and method for making same |
DE2545290A1 (en) * | 1975-10-09 | 1977-04-21 | Roehm Gmbh | METHOD OF POLYMERIZATION BY USING UV LIGHT |
CA1104782A (en) * | 1976-06-07 | 1981-07-14 | Robert E. Erickson | Absorbent films and laminates |
JPS54147696A (en) | 1978-05-12 | 1979-11-19 | Kogyo Gijutsuin | Antithrombotic elastic body |
US4272620A (en) * | 1978-08-09 | 1981-06-09 | Agency Of Industrial Science And Technology | Polyvinyl alcohol-styrylpyridinium photosensitive resins and method for manufacture thereof |
DE3582754D1 (en) * | 1984-06-04 | 1991-06-13 | Terumo Corp | MEDICAL TOOL AND PRODUCTION METHOD. |
JPS6145775A (en) * | 1984-08-07 | 1986-03-05 | テルモ株式会社 | Medical tube guide and its production |
CA1268732A (en) | 1984-12-27 | 1990-05-08 | Akira Yada | Radiation-polymerizing water-soluble cast vinyl monomer layer and forming particles |
DE3601518A1 (en) * | 1985-01-18 | 1986-07-24 | Toagosei Chemical Industrial Co., Ltd., Tokio/Tokyo | PRIMER |
US4874822A (en) * | 1988-04-07 | 1989-10-17 | Minnesota Mining And Manufacturing Company | Process for the acrylamidoacylation of alcohols |
US5091205A (en) * | 1989-01-17 | 1992-02-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydrophilic lubricious coatings |
US5008301A (en) * | 1989-02-21 | 1991-04-16 | Dow Corning Corporation | Ultraviolet curing conformal coating with dual shadow cure |
CA2019824A1 (en) | 1989-06-28 | 1990-12-28 | Seiji Arimatsu | Polyether acrylamide derivatives and active energy ray curable resin composition |
JP3162696B2 (en) * | 1989-09-06 | 2001-05-08 | ライオン株式会社 | Water-soluble, salt-sensitive polymer |
US5135516A (en) * | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
US5084315A (en) * | 1990-02-01 | 1992-01-28 | Becton, Dickinson And Company | Lubricious coatings, medical articles containing same and method for their preparation |
US5077352A (en) * | 1990-04-23 | 1991-12-31 | C. R. Bard, Inc. | Flexible lubricious organic coatings |
DK146790D0 (en) * | 1990-06-15 | 1990-06-15 | Meadox Surgimed As | PROCEDURE FOR THE PREPARATION OF A FERTILIZER COATING COATING AND MEDICAL INSTRUMENT WITH COATING COATING |
JPH0783761B2 (en) | 1990-10-04 | 1995-09-13 | テルモ株式会社 | Medical equipment |
WO1993011751A1 (en) | 1991-12-18 | 1993-06-24 | Scimed Life Systems, Inc. | Lubricous polymer network |
JP3130364B2 (en) | 1992-04-28 | 2001-01-31 | テルモ株式会社 | Surface lubricity imparting agent |
JP3227618B2 (en) | 1992-07-24 | 2001-11-12 | 昭和電工株式会社 | Manufacturing method of pre-coated fin material for heat exchanger |
US5531715A (en) * | 1993-05-12 | 1996-07-02 | Target Therapeutics, Inc. | Lubricious catheters |
JP3165939B2 (en) * | 1993-08-17 | 2001-05-14 | ソニーケミカル株式会社 | UV curable paint and optical disc |
US5670557A (en) * | 1994-01-28 | 1997-09-23 | Minnesota Mining And Manufacturing Company | Polymerized microemulsion pressure sensitive adhesive compositions and methods of preparing and using same |
US5700559A (en) * | 1994-12-16 | 1997-12-23 | Advanced Surface Technology | Durable hydrophilic surface coatings |
US5919570A (en) * | 1995-02-01 | 1999-07-06 | Schneider Inc. | Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices |
US5702754A (en) * | 1995-02-22 | 1997-12-30 | Meadox Medicals, Inc. | Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings |
US6558798B2 (en) * | 1995-02-22 | 2003-05-06 | Scimed Life Systems, Inc. | Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity |
GB9504996D0 (en) | 1995-03-11 | 1995-04-26 | Zeneca Ltd | Compositions |
US7767631B2 (en) * | 1995-06-07 | 2010-08-03 | Lee County Mosquito Control District | Lubricant compositions and methods |
US5804318A (en) * | 1995-10-26 | 1998-09-08 | Corvita Corporation | Lubricious hydrogel surface modification |
GB9522683D0 (en) | 1995-11-06 | 1996-01-10 | Coates Brothers Plc | Photoinitiator |
US5985990A (en) * | 1995-12-29 | 1999-11-16 | 3M Innovative Properties Company | Use of pendant free-radically polymerizable moieties with polar polymers to prepare hydrophilic pressure sensitive adhesive compositions |
US6238799B1 (en) * | 1996-02-09 | 2001-05-29 | Surface Solutions Laboratories, Inc. | Articles prepared from water-based hydrophilic coating compositions |
FR2755693B1 (en) * | 1996-11-14 | 1998-12-18 | Atochem Elf Sa | PROCESS FOR OBTAINING HYDROPHILIC POLYMERS WITH HIGH SPEED OF DISSOLUTION OR SWELLING IN WATER |
JPH10211273A (en) | 1997-01-29 | 1998-08-11 | Sumitomo Bakelite Co Ltd | Medical tool |
JPH10277144A (en) | 1997-04-02 | 1998-10-20 | Nippon Zeon Co Ltd | Surface lubricated medical tool |
US5877243A (en) | 1997-05-05 | 1999-03-02 | Icet, Inc. | Encrustation and bacterial resistant coatings for medical applications |
DE69801438T2 (en) | 1997-06-20 | 2002-05-16 | Coloplast A/S, Humlebaek | HYDROPHILE COATING AND METHOD FOR THEIR PRODUCTION |
JPH11172149A (en) | 1997-10-09 | 1999-06-29 | Kuraray Co Ltd | Polymer molding product with hydrophilic surface and its production |
US6310116B1 (en) * | 1997-10-09 | 2001-10-30 | Kuraray Co., Ltd. | Molded polymer article having a hydrophilic surface and process for producing the same |
US6110451A (en) * | 1998-12-18 | 2000-08-29 | Calgon Corporation | Synergistic combination of cationic and ampholytic polymers for cleansing and/or conditioning keratin based substrates |
US6835783B1 (en) * | 1999-02-24 | 2004-12-28 | Dow Global Technologies Inc. | Manufacture of superabsorbents in high internal phase emulsions |
US6565981B1 (en) * | 1999-03-30 | 2003-05-20 | Stockhausen Gmbh & Co. Kg | Polymers that are cross-linkable to form superabsorbent polymers |
US6673053B2 (en) * | 1999-05-07 | 2004-01-06 | Scimed Life Systems, Inc. | Hydrophilic lubricity coating for medical devices comprising an antiblock agent |
US6610035B2 (en) * | 1999-05-21 | 2003-08-26 | Scimed Life Systems, Inc. | Hydrophilic lubricity coating for medical devices comprising a hybrid top coat |
JP3512355B2 (en) | 1999-06-17 | 2004-03-29 | クリエートメディック株式会社 | Medical device with lubricity |
NZ520117A (en) | 2000-01-12 | 2003-02-28 | Alcon Inc | Coating of implantable ophthalmic lenses that reduce edge glare when hydrated |
US6589665B2 (en) * | 2000-05-30 | 2003-07-08 | Novartis Ag | Coated articles |
WO2001092584A1 (en) | 2000-06-02 | 2001-12-06 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
DE10043151A1 (en) | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Bone cement with antimicrobial effectiveness |
US6673453B2 (en) * | 2001-06-12 | 2004-01-06 | Biocoat Incorporated | Coatings appropriate for medical devices |
DE10146050B4 (en) * | 2001-09-18 | 2007-11-29 | Bio-Gate Ag | Process for the preparation of an antimicrobial adhesive and coating material |
WO2003035278A1 (en) * | 2001-10-25 | 2003-05-01 | Massachusetts Institute Of Technology | Method of depositing polyelectrolyte multilayers and articles coated thereby |
US20040143180A1 (en) * | 2001-11-27 | 2004-07-22 | Sheng-Ping Zhong | Medical devices visible under magnetic resonance imaging |
US20030100830A1 (en) * | 2001-11-27 | 2003-05-29 | Sheng-Ping Zhong | Implantable or insertable medical devices visible under magnetic resonance imaging |
TWI239340B (en) * | 2001-12-06 | 2005-09-11 | Nippon Catalytic Chem Ind | Process for production of water-soluble (meth)acrylic polymers, water-soluble (meth)acrylic polymers, and use thereof |
JP3936180B2 (en) * | 2001-12-07 | 2007-06-27 | 独立行政法人科学技術振興機構 | Polymer gel lubrication method |
US7115321B2 (en) * | 2002-07-26 | 2006-10-03 | Kimberly-Clark Worldwide, Inc. | Absorbent binder coating |
US6737491B2 (en) * | 2002-07-26 | 2004-05-18 | Kimberly-Clark Worldwide, Inc. | Absorbent binder composition and method of making same |
US6887961B2 (en) * | 2002-07-26 | 2005-05-03 | Kimberly-Clark Worldwide, Inc. | Absorbent binder composition and method of making it |
US6720130B1 (en) * | 2002-10-08 | 2004-04-13 | Kodak Polychrome Graphics Llc | Radiation sensitive lithographic printing plate precursors having ablation-free imageable composition and method |
US7264859B2 (en) | 2002-12-19 | 2007-09-04 | Kimberly-Clark Worldwide, Inc. | Lubricious coating for medical devices |
EP1578850B1 (en) | 2002-12-20 | 2017-02-22 | Coloplast A/S | A hydrophilic coating and a method for the preparation thereof |
IES20030294A2 (en) | 2003-04-17 | 2004-10-20 | Medtronic Vascular Connaught | Coating for biomedical devices |
US20050054774A1 (en) * | 2003-09-09 | 2005-03-10 | Scimed Life Systems, Inc. | Lubricious coating |
US7544381B2 (en) * | 2003-09-09 | 2009-06-09 | Boston Scientific Scimed, Inc. | Lubricious coatings for medical device |
WO2005037338A1 (en) * | 2003-10-14 | 2005-04-28 | Cook Incorporated | Hydrophilic coated medical device |
DE102004050868A1 (en) | 2004-10-18 | 2006-04-20 | Dreve Otoplastik Gmbh | Low-viscosity, radiation-curable formulation for the production of ear molds |
CA2589150C (en) * | 2004-11-29 | 2013-05-28 | Dsm Ip Assets B.V. | Method for reducing the amount of migrateables of polymer coatings |
US20060240060A1 (en) * | 2005-04-22 | 2006-10-26 | Cardiac Pacemakers, Inc. | Lubricious compound and medical device made of the same |
JP5042473B2 (en) | 2005-07-14 | 2012-10-03 | 互応化学工業株式会社 | Granular organic filler for curable resin composition, curable resin composition and liquid resist ink to which the granular organic filler is added |
DE102005050186A1 (en) | 2005-10-18 | 2007-04-19 | Dreve Otoplastik Gmbh | Low viscosity, radiation-hardenable composition for antimicrobial medical products, especially adaptive ear pieces, is based on e.g. (meth)acrylates, glass or silver antimicrobials and photoinitiators |
EP1957130B1 (en) | 2005-12-09 | 2010-09-15 | DSM IP Assets B.V. | Hydrophilic coating comprising a polyelectrolyte |
EP2679254A1 (en) | 2006-07-25 | 2014-01-01 | Coloplast A/S | Photo-curing of thermoplastic coatings |
US20100076546A1 (en) | 2006-09-13 | 2010-03-25 | Dsm Ip Assets B.V. | Coating formulation for medical coating |
WO2008031601A1 (en) * | 2006-09-13 | 2008-03-20 | Dsm Ip Assets B.V. | Antimicrobial hydrophilic coating comprising metallic silver particles |
CA2670582A1 (en) | 2006-12-15 | 2008-06-19 | Coloplast A/S | Coatings prepared from poly(ethylene oxide) and photo-initator-containing scaffolds |
DK2114477T3 (en) * | 2007-02-28 | 2012-08-20 | Dsm Ip Assets Bv | Hydrophilic coating |
BRPI0808118A2 (en) | 2007-02-28 | 2014-06-17 | Dsm Ip Assets Bv | HYDROPHILIC COATING |
US20110059874A1 (en) * | 2008-03-12 | 2011-03-10 | Marnix Rooijmans | Hydrophilic coating |
JP5907957B2 (en) | 2010-06-16 | 2016-04-26 | ディーエスエム アイピー アセッツ ビー.ブイ. | Coating formulations for producing hydrophilic coatings |
-
2008
- 2008-02-27 BR BRPI0808118-2A2A patent/BRPI0808118A2/en not_active Application Discontinuation
- 2008-02-27 CN CN200880006517.4A patent/CN101622019B/en active Active
- 2008-02-27 MY MYPI20093556A patent/MY148410A/en unknown
- 2008-02-27 WO PCT/EP2008/052397 patent/WO2008104573A2/en active Application Filing
- 2008-02-27 MX MX2009009145A patent/MX2009009145A/en active IP Right Grant
- 2008-02-27 EP EP08717201A patent/EP2125061A2/en not_active Withdrawn
- 2008-02-27 US US12/528,123 patent/US8513320B2/en active Active
- 2008-02-27 JP JP2009551201A patent/JP5587612B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5005287A (en) * | 1987-05-06 | 1991-04-09 | Wilkinson Sword Gmbh | Process for making a hydrophilic coating on a formed part and safety razor made using this process |
US20020002353A1 (en) * | 1998-01-30 | 2002-01-03 | Advanced Cardiovascular Systems, Inc. | Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device |
EP1065738A1 (en) * | 1999-06-28 | 2001-01-03 | Samhwa Paints Ind. Co., Ltd. | Coating material for shielding electromagnetic waves |
US20040135967A1 (en) * | 2002-12-03 | 2004-07-15 | Carney Fiona Patricia | Medical devices having antimicrobial coatings thereon |
US20050170071A1 (en) * | 2004-01-29 | 2005-08-04 | Scimed Life Systems, Inc. | Lubricious composition |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 199517 Thomson Scientific, London, GB; AN 1995-128587 XP002451204 & JP 07 053895 A (SONY CHEM CORP) 28 February 1995 (1995-02-28) * |
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9737637B2 (en) | 2004-11-29 | 2017-08-22 | Dsm Ip Assets B.V. | Method for reducing the amount of migrateables of polymer coatings |
EP1957129B1 (en) * | 2005-12-09 | 2018-02-28 | DSM IP Assets B.V. | Hydrophilic coating comprising a polyelectrolyte |
US8512795B2 (en) | 2005-12-09 | 2013-08-20 | Dsm Ip Assets B.V. | Hydrophilic coating comprising a polyelectrolyte |
US8871869B2 (en) | 2005-12-09 | 2014-10-28 | Dsm Ip Assets B.V. | Hydrophilic coating |
US8809411B2 (en) | 2007-02-28 | 2014-08-19 | Dsm Ip Assets B.V. | Hydrophilic coating |
US8513320B2 (en) | 2007-02-28 | 2013-08-20 | Dsm Ip Assets B.V. | Hydrophilic coating |
US10046093B2 (en) | 2008-09-15 | 2018-08-14 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9603973B2 (en) | 2008-09-15 | 2017-03-28 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US10117970B2 (en) | 2008-09-15 | 2018-11-06 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9034362B2 (en) | 2008-09-15 | 2015-05-19 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9132211B2 (en) | 2008-09-15 | 2015-09-15 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9198968B2 (en) | 2008-09-15 | 2015-12-01 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
JP2012502690A (en) * | 2008-09-15 | 2012-02-02 | シーヴィー インジェニュイティ コーポレイション | Local delivery of water-soluble or water-insoluble therapeutic agents to the body lumen surface |
US10314948B2 (en) | 2008-09-15 | 2019-06-11 | The Spectranetics Coporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US10987452B2 (en) | 2008-09-15 | 2021-04-27 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
WO2010079229A1 (en) | 2009-01-09 | 2010-07-15 | Dsm Ip Assets B.V. | Primer for coating coiled wires |
JP2013520277A (en) * | 2010-02-24 | 2013-06-06 | シーヴィー インジェニュイティ コーポレイション | Local delivery of water-soluble or water-insoluble therapeutic agents to the body lumen surface |
US8957125B2 (en) | 2010-06-16 | 2015-02-17 | Dsm Ip Assets B.V. | Coating formulation for preparing a hydrophilic coating |
US20170304506A1 (en) * | 2012-01-18 | 2017-10-26 | Surmodics, Inc. | Lubricious medical device coating with low particulates |
US11872325B2 (en) | 2012-01-18 | 2024-01-16 | Surmodics, Inc. | Lubricious medical device coating with low particulates |
US10905802B2 (en) * | 2012-01-18 | 2021-02-02 | Surmodics, Inc. | Lubricious medical device coating with low particulates |
US9956385B2 (en) | 2012-06-28 | 2018-05-01 | The Spectranetics Corporation | Post-processing of a medical device to control morphology and mechanical properties |
US11000632B2 (en) | 2013-01-04 | 2021-05-11 | Surmodics, Inc. | Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers |
EP4276161A3 (en) * | 2013-01-04 | 2024-01-17 | SurModics, Inc. | Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers |
US10980918B2 (en) | 2013-01-04 | 2021-04-20 | Surmodics, Inc. | Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers |
WO2014107670A1 (en) * | 2013-01-04 | 2014-07-10 | Surmodics, Inc. | Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers |
US10525171B2 (en) | 2014-01-24 | 2020-01-07 | The Spectranetics Corporation | Coatings for medical devices |
US11850370B2 (en) | 2014-08-26 | 2023-12-26 | C. R. Bard, Inc. | Urinary catheter |
US10124088B2 (en) | 2014-09-29 | 2018-11-13 | Surmodics, Inc. | Lubricious medical device elements |
US10669500B2 (en) | 2015-06-08 | 2020-06-02 | Jmedtech (Xiamen) Coating Technology Co. Ltd | Coating compositions comprising adhesion promoting base layer |
WO2016200337A1 (en) | 2015-06-08 | 2016-12-15 | Jmedtech Pte Ltd | Coating compositions comprising adhesion promoting base layer |
US11174447B2 (en) | 2015-12-29 | 2021-11-16 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US10342898B2 (en) | 2015-12-29 | 2019-07-09 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US11278647B2 (en) | 2016-03-31 | 2022-03-22 | Surmodics, Inc. | Lubricious coating for medical device |
WO2017173114A1 (en) * | 2016-03-31 | 2017-10-05 | Surmodics, Inc. | Lubricious coating for medical device |
US11123459B2 (en) | 2016-12-16 | 2021-09-21 | Surmodics, Inc. | Hydrophobic active agent particle coatings and methods for treatment |
CN108159495A (en) * | 2017-12-30 | 2018-06-15 | 深圳市拓普生物科技有限公司 | 3D bioproteins and its preparation method and application |
CN108159495B (en) * | 2017-12-30 | 2020-09-11 | 深圳市拓普生物科技有限公司 | 3D biological protein and preparation method and application thereof |
US11744925B2 (en) | 2019-01-28 | 2023-09-05 | Microvention, Inc. | Coatings |
CN112795300A (en) * | 2020-12-30 | 2021-05-14 | 邦弗特新材料股份有限公司 | UV coating and preparation method thereof |
CN112795300B (en) * | 2020-12-30 | 2022-04-22 | 邦弗特新材料股份有限公司 | UV coating and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2008104573A3 (en) | 2009-03-19 |
MX2009009145A (en) | 2009-09-03 |
BRPI0808118A2 (en) | 2014-06-17 |
EP2125061A2 (en) | 2009-12-02 |
US8513320B2 (en) | 2013-08-20 |
JP2010520317A (en) | 2010-06-10 |
MY148410A (en) | 2013-04-30 |
CN101622019A (en) | 2010-01-06 |
US20100198168A1 (en) | 2010-08-05 |
CN101622019B (en) | 2015-01-07 |
JP5587612B2 (en) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8513320B2 (en) | Hydrophilic coating | |
DK2252661T3 (en) | HYDROPHIL COATING | |
US8809411B2 (en) | Hydrophilic coating | |
US8512795B2 (en) | Hydrophilic coating comprising a polyelectrolyte | |
US20160310643A1 (en) | Coating formulation for medical coating | |
EP2252661B1 (en) | Hydrophilic coating | |
MX2008007380A (en) | Hydrophilic coating comprising a polyelectrolyte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880006517.4 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08717201 Country of ref document: EP Kind code of ref document: A2 |
|
REEP | Request for entry into the european phase |
Ref document number: 2008717201 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008717201 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009551201 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5313/DELNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/009145 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12528123 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0808118 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090828 |